NEW YORK (360Dx) – Siemens Healthineers today announced its Atellica Solution platform has received CE marking and is now available globally.

The platform, which comprises flexible, scalable, and automation-ready immunoassay and chemistry analyzers, was recently cleared by the US Food and Drug Administration, and is now commercially available in Europe, the US, South America, and Asia.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.